REHABILITATION OF THE RETINAL FUNCTION BY INNOVATIVE TECHNOLOGIES BASED ON PHOTOVOLTAIC NANOPARTICLES (Q2044169)
Jump to navigation
Jump to search
Project in Italy financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | REHABILITATION OF THE RETINAL FUNCTION BY INNOVATIVE TECHNOLOGIES BASED ON PHOTOVOLTAIC NANOPARTICLES |
Project in Italy financed by DG Regio |
Statements
12,500.0 Euro
0 references
25,000.0 Euro
0 references
50.0 percent
0 references
26 January 2018
0 references
9 December 2018
0 references
30 December 2019
0 references
RARE PARTNERS S.R.L. IMPRESA SOCIALE
0 references
Q285926 (Deleted Item)
0 references
45°28'0.48"N, 9°11'25.80"E
0 references
LA RETINITE PIGMENTOSA (RP) E LA DEGENERAZIONE MACULARE LEGATA ALL'ET (AMD) SONO MALATTIE RETINICHE DEGENERATIVE. AMBEDUE LE PATOLOGIE NON HANNO UN TRATTAMENTO CLINICO EFFICACE. IL PROGETTO DI COLLABORAZIONE TRA RARE PARTNERS E IL GRUPPO DI RICERCA DEL CENTER FOR NANOSCIENCE AND TECHNOLOGY DELLISTITUTO ITALIANO DI TECNOLOGIA, DIRETTO DAI PROFF. G. LANZANI E F. *individuo* A FORNIRE UNA SOLUZIONE DI CLINICA RILEVANZA PER RP E AMD. IL PROGETTO, DENOMINATO NANOSPARKS SI PROPONE DI UTILIZ (Italian)
0 references
THE RETINITIS PIGMENTOSA (RP) AND THE MACULAR DEGENERATION (AMD) ARE DEGENERATIVE RETINAL DISEASE. BOTH DISEASES DO NOT HAVE ANY EFFECTIVE CLINICAL TREATMENT. THE COLLABORATIVE PROJECT BETWEEN RARE PARTNERS AND THE RESEARCH TEAM OF THE CENTER FOR NANOSCIENCE AND TECHNOLOGY DELLISTITUTO ITALIAN TECHNOLOGY, HEADED BY PROFF. G. LANZANI E F. * individual * A FORNRE A RESOLUTION OF CLINICA SOLUTION FOR RP AND AMD THE PROJECT IS CALLED NANOSPARKS: (English)
0 references
Identifiers
E47H18000570007
0 references